U.S. approves antibiotic to fight anthrax September 1, 2000
Web posted at: 3:50 PM EDT (1950 GMT)
WASHINGTON (Reuters) -- U.S. health officials, working to prepare the United States to face the threat of biological terrorism, Thursday approved a widely used antibiotic to fight infection with the deadly agent, anthrax.
Children also could receive Cipro treatment for anthrax exposure because the disease is so lethal, the FDA said. The drug, which has been on the market since 1987, had not previously been approved for children because of concerns about long-term safety.